Renaud J P, Moras D
Laboratoire de Biologie et Génomique Structurales, CNRS UPR 9004, Institut de Génétique et Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, B.P. 163, Illkirch, France.
Cell Mol Life Sci. 2000 Nov;57(12):1748-69. doi: 10.1007/PL00000656.
Nuclear receptors are DNA-binding factors which regulate the transcription of sets of specific genes in response to cognate ligands, usually small lipophilic molecules, thus controlling numerous physiological events in development, procreation, homeostasis, and cellular life. Their ligand-dependent activity makes nuclear receptors obvious targets for drug design in many therapeutic areas. Crystallographic studies have revealed the structure of isolated domains but not, yet, of a whole protein, probably due to an intrinsic flexibility at work in nuclear receptor action. The structure of DNA-binding domain dimers in complex with an oligonucleotide has brought insights into how nuclear receptors recognize and bind to their target sequences ('response elements'). The structure of several ligand-binding domains in different ligation states has provided evidence for a ligand-dependent transcriptional switch and a molecular basis for the mode of action of agonists and antagonists.
核受体是一类DNA结合因子,它们能够响应同源配体(通常是亲脂性小分子),调控特定基因集的转录,从而控制发育、生殖、体内平衡及细胞生命活动中的众多生理过程。它们依赖配体的活性使得核受体在许多治疗领域成为药物设计的明显靶点。晶体学研究揭示了分离结构域的结构,但尚未揭示完整蛋白质的结构,这可能是由于核受体作用过程中存在内在的灵活性。与寡核苷酸复合的DNA结合结构域二聚体的结构,为核受体如何识别并结合其靶序列(“反应元件”)提供了见解。处于不同结合状态的几个配体结合结构域的结构,为配体依赖性转录开关提供了证据,并为激动剂和拮抗剂的作用模式提供了分子基础。